FDA product code NCG: Neuropsychiatric Interpretative Electroencephalograph Assessment Aid

NCG is the FDA product code for neuropsychiatric interpretative electroencephalograph assessment aid. It is a Class II device, regulated under 21 CFR 882.1440 and reviewed by the Neurology panel. FDA has cleared 2 510(k) submissions under NCG, 2 in the last five years, from 2 different applicants. The average 510(k) review took 158 days (median 158); 167 days on average over the last three years. 1 De Novo request was granted under it.

Definition

Uses a patient's electroencephalograph (EEG) to provide an interpretation of the patient's neuropsychiatric condition. It is also used only as an assessment aid for a medical condition for which there exists other valid methods of diagnosis."

Classification

FieldValue
Device nameNeuropsychiatric Interpretative Electroencephalograph Assessment Aid
Device classClass II
Regulation21 CFR 882.1440
Review panelNE — Neurology
Medical specialtyNeurology
Premarket route510(k)

510(k) clearances per year for NCG

YearClearancesAvg. review days
20231149
20251167

Compare with all 510(k) review times · Search every NCG clearance

Top NCG applicants

ApplicantClearancesLatest
Ceribell, Inc.12025-12-08
Prolira B.V.12023-02-02

Most recent NCG clearances

510(k)ApplicantDeviceDecision dateReview days
K251936Ceribell, Inc.Ceribell Delirium Monitor System2025-12-08167
K222680Prolira B.V.DeltaScan Monitor2023-02-02149

Recalls for NCG devices

openFDA lists no recalls for product code NCG.

Frequently asked questions

What is FDA product code NCG?

NCG is the FDA product code for neuropsychiatric interpretative electroencephalograph assessment aid. It is a Class II device, regulated under 21 CFR 882.1440 and reviewed by the Neurology panel.

What device class is NCG?

Class II, regulation 21 CFR 882.1440. Typical premarket route: 510(k).

How long does a 510(k) take for product code NCG?

Across 2 cleared submissions the average was 158 days from receipt to decision (median 158).

Which companies have the most NCG clearances?

Ceribell, Inc. (1); Prolira B.V. (1).

Next steps

Source: openFDA device classification, 510(k), PMA, De Novo and recall data (public domain). Review days run from FDA receipt to decision. Not regulatory advice.

All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times